Elite Pharmaceuticals (ELTP) Stock Chart & Stock Price History → The Gold Grab of the Century (From Colonial Metals) (Ad) Free ELTP Stock Alerts $0.13 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Elite Pharmaceuticals Stock Price Performance5 Day Performance+7.55%1 Month Performance-14.15%3 Month Performance-30.26%6 Month Performance+12.50%Year-To-Date Performance-5.36%1 Year Performance+301.52% Receive ELTP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself ELTP Stock Chart for Sunday, April, 28, 2024 ELTP Chart by TradingView Elite Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$0.13$0.13+2.32%$0.13$0.13290,097 shs$141.55 million04/25/2024$0.13$0.13+2.94%$0.13$0.13210,610 shs$138.34 million04/24/2024$0.12$0.13+2.11%$0.13$0.12941,209 shs$134.39 million04/23/2024$0.13$0.12-3.14%$0.13$0.12452,903 shs$131.61 million04/22/2024$0.13$0.13-2.15%$0.13$0.12611,836 shs$135.88 million04/19/2024$0.13$0.13-2.62%$0.13$0.13731,258 shs$138.88 million Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.14$0.13-1.69%$0.14$0.1384,829 shs$142.61 million04/17/2024$0.14$0.14-0.80%$0.14$0.13227,642 shs$145.07 million04/16/2024$0.14$0.14+1.41%$0.14$0.13202,900 shs$146.25 million04/15/2024$0.14$0.14-3.57%$0.14$0.13298,369 shs$144.22 million04/12/2024$0.14$0.14+0.07%$0.14$0.13222,211 shs$149.56 million04/11/2024$0.14$0.14-0.57%$0.14$0.14245,027 shs$149.45 million04/10/2024$0.14$0.14-0.21%$0.14$0.13957,070 shs$150.31 million04/09/2024$0.14$0.14+0.71%$0.14$0.13605,200 shs$150.63 million04/08/2024$0.14$0.14+1.60%$0.15$0.13580,956 shs$149.56 million04/05/2024$0.14$0.14+1.60%$0.14$0.13580,956 shs$142.49 million04/04/2024$0.14$0.14-1.57%$0.14$0.131.07 million shs$140.25 million04/03/2024$0.15$0.14-8.50%$0.15$0.141.01 million shs$142.49 million04/02/2024$0.15$0.15$0.16$0.14349,198 shs$155.72 million04/01/2024$0.15$0.15-0.87%$0.16$0.15232,283 shs$155.72 million03/29/2024$0.15$0.15$0.16$0.15500,606 shs$157.08 million03/28/2024$0.15$0.15+0.88%$0.16$0.15497,297 shs$157.08 million03/27/2024$0.15$0.15+0.43%$0.16$0.15170,933 shs$155.72 million03/26/2024$0.15$0.15+0.36%$0.16$0.14352,404 shs$155.06 million03/25/2024$0.15$0.15+0.40%$0.16$0.141.70 million shs$154.50 million03/22/2024$0.15$0.15-1.11%$0.15$0.15209,759 shs$153.89 million03/21/2024$0.15$0.15+2.69%$0.16$0.15635,664 shs$155.62 million03/20/2024$0.14$0.15+3.40%$0.15$0.14487,826 shs$151.55 million03/19/2024$0.14$0.14$0.15$0.14479,157 shs$146.56 million03/18/2024$0.14$0.14+0.01%$0.15$0.14461,900 shs$146.56 million03/15/2024$0.14$0.14$0.14$0.13264,799 shs$141.47 million03/14/2024$0.14$0.14+0.36%$0.14$0.13231,549 shs$141.47 million03/13/2024$0.13$0.14+3.36%$0.14$0.13790,360 shs$140.96 million03/12/2024$0.15$0.13-7.65%$0.15$0.131.92 million shs$136.38 million03/11/2024$0.15$0.15-4.54%$0.15$0.141.37 million shs$147.68 million03/08/2024$0.15$0.15-1.30%$0.15$0.14716,520 shs$154.70 million03/07/2024$0.16$0.15-1.22%$0.16$0.15341,674 shs$156.74 million03/06/2024$0.15$0.16+3.11%$0.16$0.15507,387 shs$158.67 million03/05/2024$0.16$0.15-4.92%$0.16$0.151.25 million shs$153.88 million03/04/2024$0.17$0.16-4.55%$0.17$0.16899,688 shs$161.85 millionThese AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy03/01/2024$0.16$0.17+3.48%$0.17$0.161.19 million shs$169.56 million02/29/2024$0.16$0.16-0.31%$0.17$0.16463,048 shs$163.86 million02/28/2024$0.16$0.16+1.89%$0.17$0.16456,821 shs$164.37 million02/27/2024$0.15$0.16+7.09%$0.17$0.16589,738 shs$161.32 million02/26/2024$0.15$0.15$0.17$0.145.71 million shs$150.63 million02/23/2024$0.16$0.15-8.92%$0.16$0.145.71 million shs$150.63 million02/22/2024$0.18$0.16-7.93%$0.18$0.154.78 million shs$165.39 million02/21/2024$0.18$0.18-2.70%$0.19$0.171.36 million shs$179.64 million02/20/2024$0.19$0.18-4.53%$0.19$0.181.44 million shs$184.63 million02/19/2024$0.19$0.19$0.20$0.181.17 million shs$193.38 million02/16/2024$0.18$0.19+2.76%$0.20$0.181.17 million shs$193.38 million02/15/2024$0.20$0.18-5.18%$0.21$0.184.04 million shs$188.19 million02/14/2024$0.19$0.20+2.74%$0.20$0.191.05 million shs$198.47 million02/13/2024$0.19$0.19-0.11%$0.20$0.191.10 million shs$193.18 million02/12/2024$0.19$0.19$0.20$0.191.65 million shs$193.38 million02/09/2024$0.19$0.19-2.51%$0.20$0.191.45 million shs$193.38 million02/08/2024$0.20$0.19-0.56%$0.20$0.191.43 million shs$198.37 million02/07/2024$0.19$0.20+1.82%$0.20$0.191.08 million shs$199.49 million02/06/2024$0.19$0.19+0.57%$0.20$0.191.39 million shs$195.92 million02/05/2024$0.18$0.19+4.45%$0.20$0.18865,007 shs$194.80 million02/02/2024$0.18$0.18-0.65%$0.19$0.181.11 million shs$186.56 million02/01/2024$0.19$0.18-1.81%$0.20$0.181.26 million shs$187.78 million01/31/2024$0.19$0.19+1.46%$0.20$0.181.66 million shs$191.24 million01/30/2024$0.19$0.19-2.83%$0.19$0.191.04 million shs$188.49 million01/29/2024$0.19$0.19+0.32%$0.20$0.18768,225 shs$193.99 million Related Companies: Annovis Bio Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Vistagen Therapeutics Stock Price Chart Zomedica Stock Price Chart Sagimet Biosciences Stock Price Chart Syros Pharmaceuticals Stock Price Chart Karyopharm Therapeutics Stock Price Chart Repare Therapeutics Stock Price Chart Citius Pharmaceuticals Stock Price Chart Biophytis Stock Price Chart Receive ELTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ELTP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.